Malnutrition is an Independent Risk Factor on Survival on EGFR Mutated Patients Diagnosed with Non-Small Cell Lung Cancer

被引：0
作者：
De la Torre-Vallejo, Martha
Luvian-Morales, Julissa
Gonzalez-Ling, Ana
Turcott, Jenny
Arrieta, Oscar
机构：
[1] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol, Lab Personalized Med, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
D O I：
10.1016/j.jtho.2016.11.2164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.05-002
引用
收藏
页码：S1413 / S1413
页数：1
相关论文
共 50 条
[41]   Critical points in the management of EGFR-mutated non-small cell lung cancer [J].
Casaluce, Francesca ;
Gridelli, Cesare .
JOURNAL OF THORACIC DISEASE, 2022, 14 (06) :1748-1752
[42]   Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer [J].
Shepherd, Annemarie F. ;
Preeshagul, Isabel R. ;
Shaverdian, Narek ;
Wu, Abraham J. ;
Gelblum, Daphna Y. ;
Gomez, Daniel R. ;
Rimner, Andreas ;
Simone, Charles B., II .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
[43]   Characterizing the evolution of osimertinib resistance in EGFR mutated non-small cell lung cancer [J].
Dinh, Mina N. ;
Wu, Jinling ;
Hitomi, Masahiro ;
Strobl, Maximilian ;
Scott, Jacob G. .
CANCER RESEARCH, 2025, 85 (08)
[44]   Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer [J].
Leonetti, Alessandro ;
Sharma, Sugandhi ;
Minari, Roberta ;
Perego, Paola ;
Giovannetti, Elisa ;
Tiseo, Marcello .
BRITISH JOURNAL OF CANCER, 2019, 121 (09) :725-737
[45]   Outcomes of KRAS mutated, EGFR mutated, ALK mutated and wildtype patients in non-small cell lung cancer brain metastases. [J].
Rauf, Yasmeen ;
Tatineni, Vineeth ;
Oshea, Patrick Joseph ;
Jia, Xuefei ;
Peereboom, David M. ;
Ahluwalia, Manmeet Singh .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[46]   NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER [J].
Ianza, A. ;
Dicorato, A. ;
Guglielmi, A. ;
Orlando, V. ;
Furlanis, G. ;
Curro, F. .
CHEST, 2022, 161 (06) :333A-333A
[47]   Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer [J].
Alessandro Leonetti ;
Sugandhi Sharma ;
Roberta Minari ;
Paola Perego ;
Elisa Giovannetti ;
Marcello Tiseo .
British Journal of Cancer, 2019, 121 :725-737
[48]   Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer [J].
Forde, Patrick M. ;
Ettinger, David S. .
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) :528-532
[49]   Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer [J].
Ali, Azhar ;
Levantini, Elena ;
Teo, Jun Ting ;
Goggi, Julian ;
Clohessy, John G. ;
Wu, Chan Shuo ;
Chen, Leilei ;
Yang, Henry ;
Krishnan, Indira ;
Kocher, Olivier ;
Zhang, Junyan ;
Soo, Ross A. ;
Bhakoo, Kishore ;
Chin, Tan Min ;
Tenen, Daniel G. .
EMBO MOLECULAR MEDICINE, 2018, 10 (03)
[50]   The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer [J].
Chang, John Wen-Cheng ;
Chang, Ching-Fu ;
Huang, Chen-Yang ;
Yang, Cheng-Ta ;
Kuo, Chih-Hsi Scott ;
Fang, Yueh-Fu ;
Hsu, Ping-Chih ;
Wu, Chiao-En .
THORACIC CANCER, 2023, 14 (04) :348-356
12345